Porphyria cutanea tarda associated with methotrexate therapy.
A 69-year-old lady with RA developed porphyria cutanea tarda 2 weeks following initiation of methotrexate therapy. The clinical and laboratory features are described.
O'Neill
T
T
Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath.
Simpson
J
J
Smyth
S J
SJ
Lovell
C
C
Calin
A
A
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology
D008727:Methotrexate